Remove rutgers-receives-fda-approval-for-cancer-therapy-clinical-trials
article thumbnail

Rutgers Receives FDA Approval for Cancer Therapy Clinical Trials

Dimensions of Dental Hygiene

Actinobac Biomed, a company founded by Rutgers School of Dental Medicine researcher Scott Kachlany, PhD, has received U.S. Food and Drug Administration approval to begin a Phase I clinical trial in patients who have relapsed or refractory leukemia of lymphoma, according to the college. Learn more at newswise.com.

52